The board may think this is a successful CR, however, I think the shareholders that did not subscribe may not share the same sentiment.
Until this board start making real progress and show some results I am afraid I will sit on the sidelines and lick my wounds. Not much point in putting Vitrogro on them as its still not approved despite the numerous claims and backslapping that has went on at TIS.
